The effect of riluzole in amyotrophic lateral sclerosis: A study with cortical stimulation

Journal of the Neurological Sciences

Volumn 169, Issue 1-2, 1999, Pages 98-107

  Desiato, M T ^a   Palmieri, M G ^b   Giacomini, P ^c   Scalise, A ^a   Arciprete, F ^a   Caramia, M D ^b  

^a Univ Roma T   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Amyotrophic lateral sclerosis; Motor evoked potential; Paired magnetic stimulation; Riluzole; Silent period

Indexed keywords

RILUZOLE;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EVOKED MUSCLE RESPONSE; FEMALE; HUMAN; MALE; MOTOR NEURON DISEASE; MUSCLE STRENGTH; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANALYSIS OF VARIANCE; ELECTRIC STIMULATION; ELECTROMAGNETICS; EVOKED POTENTIALS, MOTOR; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RILUZOLE;

EID: 0032720023     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(99)00225-7     Document Type: Article

References (34)

1. Herdmann J., Reiners K., Freund H.J. Motor unit recruitment order in neurogenic disease. Electromyogr Clin Neurophysiol. 28:1988;53-60.
2. Eisen A., Seung K., Bhanu P. Amyotrophic Lateral Sclerosis (ALS): a phylogenetic disease of the corticomotoneuron? Muscle Nerve. 15:1992;219-228.
3. Nakajima M., Eisen A.A., Stewart H. Abnormalities of corticomotoneuronal excitatory postsynaptic potentials in functioning motor units in amyotrophic lateral sclerosis. Muscle Nerve. 20:(8):1997;1053.
4. Martin D., Thompson M.A., Nadler J.V. The neuroprotective agent riluzole inhibits release of glutamate and aspartate from slices of hippocampal area CA1. Eur J Pharmacol. 250:(3):1993;473-476.
5. Siniscalchi A., Bonci A., Mercuri N.B., Bernardi G. Effects of riluzole on rat cortical neurones: an in vitro electrophysiological study. Br J Pharmacol. 120:1997;225-230.
6. Rothstein J.D., Van Kammen M., Levey A.I., Martin L., Kuncl R.W. Selective loss of glial glutamate transporter GTL-1 in Amyotrophic Lateral Sclerosis. Ann Neurol. 38:1995;73-84.
7. Doble A. The pharmacology and mechanism of action of riluzole. Neurology. 47:(Suppl 4):1996;S233-S241.
8. Mizoule J., Meldrum B., Mazadier M., et al. 2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission: I anticonvulsant properties. Neuropharmacology. 24:1985;767-773.
9. Eisen A., Stewart H., Schulzer M., Cameron D. Anti-glutamate therapy in amyotrophic lateral sclerosis: a trial using lamotrigine. Can J Neurol Sci. 20:(4):1993;297-301.
10. Bensimon G., Lacomblez L., Meininger V., et al. A controlled trial of riluzole in amyotrophic lateral sclerosis. New Engl J Med. 330:1994;585-591.
11. Lacomblez L., Bensimon G., Leigh P.N., et al. A confirmatory dose-ranging study of riluzole in ALS. Neurology. 47:(Suppl 4):1996;S242-S250.
12. Riviere M., Meininger V., Zeisser P., Munsat T. An analysis of extended survival in patients with amyotrophic lateral sclerosis treated with riluzole. Arch Neurol. 55:(4):1998;526-528.
13. Caramia M.D., Cicinelli P., Paradiso C., Mariorenzi R., Zarola F., Bernardi G., Rossini P.M. Excitability changes of muscular responses to magnetic brain stimulation in patients with central motor disorders. Electroencephalogr Clin Neurophysiol. 81:1991;243-250.
14. Desiato M.T., Caramia M.D., Rossini P.M., Iani C., Bernardi G. Amyotrophic lateral sclerosis: correlation between clinical picture and neurophysiological testing. Can J Neurol Sci. 4:(Suppl):1993;84.
15. Alister J., Eisen A.A. The cortical silent period and Amyotrophic Lateral Sclerosis. Muscle Nerve. 17:1994;217-223.
16. Claus D., Brunhölzl F.P., Kerling F.P., Henschel S. Transcranial magnetic stimulation as a diagnostic and prognostic test in amyotrophic lateral sclerosis. J Neurol Sci. 139:(Suppl):1995;30-34.
17. Mills K.R. Motor Neuron Disease studies of the corticospinal excitation of single motor neurons by magnetic brain stimulation. Brain. 118:1995;971-982.
18. Desiato M.T., Caramia M.D. Towards a neurophysiological marker of amyotrophic lateral sclerosis as revealed by changes in cortical excitability. Electroencephalogr Clin Neurophysiol. 105:1997;1-7.
19. Ziemann U., Winter M., Reimers C.D., Reimers K., Tergau F., Paulus W. Impaired motor cortex inhibition in patients with amyotrophic lateral sclerosis. Neurology. 49:1997;1292-1298.
20. J Neurol Sci. 124:(Suppl):1994;96-107.
21. Norris F.H. Jr, Calanchini P.R., Fallat R.J., Panchari S., Jewett B. Administration of guanidine in amyotrophic lateral sclerosis. Neurology. 24:(8):1974;721-728.
22. Caramia M.D., Pardal A.M., Zarola F., Rossini P.M. Electric vs magnetic transcranial stimulation of the brain in healthy humans: a comparative study of central motor tracts 'conductivity' and 'excitability'. Brain Res. 479:1989;431-436.
23. Rossini P.M., Barker A.T., Berardelli A., Caramia M.D., Caruso G., Cracco R.Q., et al. Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee. Electroencephalogr Clin Neurophysiol. 91:(2):1994;79-92.
24. Rossini P.M., Desiato M.T., Lavaroni F., Caramia M.D. Brain excitability and electroencephalographic activation: non-invasive evaluation in healthy humans via transcranial magnetic stimulation. Brain Res. 565:1991;111-123.
25. Kujirai T., Caramia M.D., Rothwell J.C., Day B.L., Thompson P.D., Ferbert A., Wroe S., Asselman P., Marsden C.D. Corticocortical inhibition in human motor cortex. J Physiol. 471:1993;501-519.
26. Caramia M.D., Gigli G.L., Iani C., Desiato M.T., Diomedi M., Palmieri G., Bernardi G. Distinguishing forms of generalised epilepsy using magnetic brain stimulation. Electroencephalogr Clin Neurophysiol. 98:1996;14-19.
27. Cantello R., Gianelli M., Cirardi C., Mutani R. Magnetic brain stimulation: the silent period after the motor evoked potentials. Neurology. 42:1990;1951-1959.
28. Triggs W.J., Macdonell R.A.L., Cros D., Chiappa K.H., Shahani B.T., Day B.J. Motor inhibition and excitation are independent effects of magnetic cortical stimulation. Ann Neurol. 32:1992;345-351.
29. Desai J., Sharief M., Swash M. Riluzole has no effect on motor unit parameters in ALS. J Neurol Sci. 1998;S69-S72.
30. Di Lazzaro V., Restuccia D., Oliviero A., Profice P., Ferrara L., Insola A., Mazzone P., Tonali P., Rothwell J.C. Magnetic transcranial stimulation at intensities below active motor threshold activates intracortical inhibitory circuits. Exp Brain Res. 119:1998;265-268.
31. Yokota T., Yoshino A., Inaba A., Saito Y. Double cortical stimulation in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 61:1996;596-600.
32. Hanajima R., Ugawa Y., Terao Y., Ogata K., Kanazawa I. Ipsilateral cortico-cortical inhibition of the motor cortex in various neurological disorders. J Neurol Sci. 140:1996;109-116.
33. Kalra S., Cashman N.R., Genge A., Arnold D.L. Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy. Neuroreport. 9:(8):1998;1757-1761.
34. Fuhr P., Agostino R., Hallet M. Spinal motor neuron excitability during the silent period after cortical stimulation. Electroencephalogr Clin Neurophysiol. 81:1991;257-262.